SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022860
Filing Date
2020-05-07
Accepted
2020-05-07 16:12:45
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20200331.htm   iXBRL 10-Q 2147686
2 EX-10.1 arwr-ex101_202.htm EX-10.1 94295
3 EX-31.1 arwr-ex311_7.htm EX-31.1 10404
4 EX-31.2 arwr-ex312_6.htm EX-31.2 10925
5 EX-32.1 arwr-ex321_8.htm EX-32.1 6308
6 EX-32.2 arwr-ex322_9.htm EX-32.2 6555
  Complete submission text file 0001564590-20-022860.txt   6407791

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20200331.xsd EX-101.SCH 41512
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20200331_cal.xml EX-101.CAL 48446
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20200331_def.xml EX-101.DEF 137751
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20200331_lab.xml EX-101.LAB 368011
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20200331_pre.xml EX-101.PRE 282261
28 EXTRACTED XBRL INSTANCE DOCUMENT arwr-10q_20200331_htm.xml XML 899573
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 20856503
SIC: 2834 Pharmaceutical Preparations